3 BRIC-related clinical projects win funding.

Congratulations to Pierre-Yves DUMAS, PUPH team 10 (Normal and Leukemic Hematopoietic Stem Cells), who has been awarded funding from the PHRCI 2024 Interregional Clinical Research Program proposed by the GIRCI SOHO (Interregional Group for Clinical Research and Innovation – South-West, Overseas Hospitals). The project developed within the Clinical Hematology and Cell Therapy Department of Bordeaux University Hospital is a clinical trial aiming at improving the treatment of patients with FLT3-mutated acute myeloid leukemia eligible for intensive chemotherapy.
BRIC collaborators, team 10: Jean-Max Pasquet (team leader), Amélie Guitart, Vanessa Desplat and Isabelle Vigon.

Congratulations also to the winners of the Bordeaux University Hospital‘s 2024 internal call for tenders.

Dr Arthur MARICHEZ, PhD clinician in team 3 (Liver Cancers and Tumor Invasion) for the funding of the clinical project, in connection with his PhD thesis in our unit under the supervision of Pr Laurence Chiche, in the team headed by Frédéric Saltel and Violaine Moreau.

The PROFI-CHOL study is being developed in the Digestive Surgery Department of Bordeaux University Hospital, with the aim of validating a proof of concept of proteomic profiling as a diagnostic tool for extrahepatic cholangiocarcinoma on a cohort of patients from Bordeaux University Hospital. This study is being carried out in collaboration with the Oncoprot platform (TBMcore 3427) and the pathologists at Hôpital Haut Lévêque: Dr G. Belleannée, Dr M. Marty.

Dr Eva JAMBON, PhD clinician, Emerging Team 12 (Integrated Research Innovation Program on Kidney Cancer – I.CaRe), for the funding of a clinical project in connection with her PhD thesis, which will soon be starting in our unit, in the team headed by Jean-Christophe Bernhard. The project concerns the development of multiparametric MRI imaging of the graft. The aim of the KETCHUP study is to distinguish the causes of renal graft failure using multiparametric MRI in order, ultimately, to reduce the indications for biopsy.

This project is in collaboration with other members of the unit: Pr Amandine Crombe (Team 9 Sarcotarget) in radiomics, and researchers from the ImmunoConcept laboratory: Pr Hannah Kaminski in Nephrology and Dr Bertrand Chauveau in Pathology.

Congratulations also to Dr. Lucie CHANSEL-DEBORDEAUXteam 8 (Genetic Biotherapies and Oncology – BioGO) for the funding of her clinical project, unrelated to her activities at BRIC.